Skip to main content

Month: February 2024

Kaldalón hf.: SAND hótel fær alþjóðlega BREEAM umhverfisvottun

SAND hótel og tengdar fasteignir Kaldalóns við Laugaveg 32-36 í Reykjavík hafa hlotið umhverfisvottun BREEAM In-Use. Um er að ræða fyrsta hótelið á Íslandi sem að fær slíka vottun en niðurstaða einkunnar er „mjög góð (e. Very Good)“. Rekstraraðili hótelsins er KEA hótel. BREEAM vistvottunarkerfið byggir á alþjóðlegum staðli fyrir byggingar í rekstri þar sem óháður vottunaraðili auk BRE Global Limited staðfesta ágæti fasteignar. Úttekt og vottun fasteignarinnar hjálpar rekstraraðilum og fasteignaeigendum við yfirsýn og umbætur á ýmsum þáttum sjálfbærni en þeir helstu eru heilsa og vellíðan starfsfólks og gesta, orkunotkun, mengun og umhverfisgæði. Vottun fasteignanna er í samræmi við stefnu Kaldalóns um sjálfbærni og þá vegferð sem félagið hefur kynnt við útgáfu grænna skuldabréfa. SAND hótel og tengdar fasteignir tilheyra almenna tryggingafyrirkomulaginu...

Continue reading

CMP 2022 Resource Limited Partnership completes rollover into Dundee Global Resource Class

TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) — Goodman & Company, Investment Counsel Inc. (“GCIC”) is pleased to announce that CMP 2022 Resource Limited Partnership (“CMP 2022”) has completed the transfer of assets into Dundee Global Fund Corporation in exchange for shares of Dundee Global Resource Class. On the date of transfer, February 2, 2024, the net asset value for CMP 2022 was $301.49 per Class A Unit and $348.73 per Class F Unit. The net asset value for Dundee Global Resource Class was $4.67 per Series A Share and $5.10 per Series F Share. Upon the dissolution of CMP 2022, on or about February 15, 2024, shares of Dundee Global Resource Class will be distributed to the limited partners of CMP 2022 (“Limited Partners”). In the interim, Limited Partners can determine a value for their holdings in Dundee Global Resource Class...

Continue reading

Bay Community Bancorp Earns $1.31 Million in Fourth Quarter 2023 and a Record $8.23 Million for the Year; Declares Quarterly Cash Dividend of $0.05 Per Share

OAKLAND, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Bay Community Bancorp, (OTCPink: CBOBA) (the “Company”), parent company of Community Bank of the Bay, (the “Bank”) a San Francisco Bay Area commercial bank and California’s first certified FDIC-insured Community Development Financial Institution (“CDFI”) with full-service offices in Oakland, Danville, San Jose and San Mateo, today reported net income of $1.31 million for the fourth quarter of 2023, compared to $2.39 million for the fourth quarter of 2022. In the third quarter of 2023, the Company earned $3.12 million, which included a $2.48 million Equitable Recovery Program (“ERP”) grant, as well as $437,000 Bank Enterprise Award (“BEA”). All financial results are unaudited. For the year 2023, net income increased 2.1% to a record $8.23 million, compared to $8.06 million in 2022....

Continue reading

Mesa Labs Announces Third Quarter Results

LAKEWOOD, Colo., Feb. 05, 2024 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q24”) ended December 31, 2023. Third quarter FY 2024 compared to third quarter FY 2023:Revenues decreased 1.5% but increased 0.6% vs 2Q24 Non-GAAP core organic revenues3 decreased 9% Operating income decreased 102% Non-GAAP adjusted operating income1 excluding unusual items decreased 6.8% but increased 7.3% vs 2Q24 Non-GAAP adjusted operating income excluding unusual items as a percentage of revenues increased sequentially to 22.4%Executive Commentary (amounts in thousands) “Revenues of $53,473 for the quarter decreased 1.5% as compared to the third quarter of fiscal year 2023...

Continue reading

Gorilla Technology Group Reports Results Through Third Quarter 2023

– Q3 revenues far exceeded total revenue of 2022 – – High value Product driven & Services business model reflected in 76.5% gross margin –– Won sales exceeded internal target of $68 million, standing at $300 million (a 441% increase) –– Achieved discounted run rate revenues of $88 million in Q3 –– Solid visibility with sales pipeline over $1 billion – LONDON, Feb. 05, 2024 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI-based edge video analytics, IoT technologies, and security convergence, today reported financial results for the nine months ending September 30, 2023. YTD HighlightsSurging Revenue: Nine-month revenue of $37.9 million surged by over 2x versus the same period, last year.High and Expanding Margin Reflects Value of Business Model: The robust 76.5% gross...

Continue reading

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

CAMBRIDGE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO will present at the Canaccord Genuity Musculoskeletal Conference. The presentation is scheduled to begin at 11:00 a.m. ET (8:00 a.m. PT) on Monday, February 12, 2024. A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com. About Vericel Corporation Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics...

Continue reading

eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of cancer, today announced that Steve Worland, Ph.D., president, and chief executive officer of eFFECTOR, will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Wednesday, February 14th at 10:40 am ET. A live webcast of the virtual presentations will be available on the “Events and Presentations” page of the Investors section of the Company’s website with a replay available for 90 days following the event. For more information, please visit investors.effector.com. About eFFECTOR Therapeutics eFFECTOR is a clinical-stage biopharmaceutical company pioneering the development...

Continue reading

Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

BOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that Robert Connelly, Chief Executive Officer, will present at the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference on February 13, 2024 at 12:40 PM ET. A live webcast of the presentation will be accessible under “Events” in the Investors section of Elicio’s website and will be available on-demand for 90 days following the event. About Elicio TherapeuticsElicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer. By combining expertise in immunology and immunotherapy, Elicio is engineering...

Continue reading

InterDigital Announces Convertibility of 3.50% Senior Convertible Notes Due 2027

WILMINGTON, Del., Feb. 05, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, announced today that, pursuant to the terms of the Indenture governing its 3.50% Senior Convertible Notes due 2027 (the “Notes”), the Notes are convertible during its calendar quarter ending March 31, 2024. The current conversion rate of the Notes is 12.9041 shares of InterDigital’s Common Stock per $1,000 principal amount of the Notes. Upon the conversion of any Notes, InterDigital will pay cash up to the aggregate principal amount of the Notes to be converted, and will pay cash, shares of its Common Stock or a combination of cash and shares of its Common Stock for any conversion obligation in excess of the aggregate principal amount being converted, if any, at InterDigital’s election,...

Continue reading

Blüm Holdings Refocuses on Cannabis Retail and Brand Leadership with Strategic Sale of Cultivation Assets

SANTA ANA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Blum Holdings, Inc. (OTCQB: UNRVD) (“Company,” “Blüm Holdings”, “we” or “us”), a cannabis company with operations throughout California, announces its wholly-owned subsidiary Unrivaled Brands’ divestment of its final California cultivation facility, a decision which aligns to a broader realignment strategy concentrating the Company’s efforts on operating and expanding profitable cannabis assets and developing brands. Sabas Carrillo, Chief Executive Officer of Blüm Holdings, commented on the decision, “As we navigate the dynamic cannabis landscape, our strategic focus must be on sustained growth, cash generation, and profitability. The divestiture of our final California cultivation facility positions the Company to concentrate on the cannabis retail market and on our...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.